Process for preparation of regorafenib crystalline forms

摘要

ABSTRACT The present invention relates to a process for the preparation crystalline forms of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide or Regorafenib of Formula (I). (I)